Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction
D. Julia Trembinski, Diewertje I. Bink, Kosta Theodorou and 29 more
Nature Communications · 2020
doi:10.1038/s41467-020-15995-2 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Long non-coding RNAs (lncRNAs) contribute to cardiac (patho)physiology. Aging is the major risk factor for cardiovascular disease with cardiomyocyte apoptosis as one underlying cause. Here, we report the identification of the aging-regulated lncRNA Sarrah (ENSMUST00000140003) that is anti-apoptotic in cardiomyocytes. Importantly, loss of SARRAH ( OXCT1-AS1 ) in human engineered heart tissue results in impaired contractile force development. SARRAH directly binds to the promoters of genes downregulated after SARRAH silencing via RNA-DNA triple helix formation and cardiomyocytes lacking the triple helix forming domain of Sarrah show an increase in apoptosis. One of the direct SARRAH targets is NRF2, and restoration of NRF2 levels after SARRAH silencing partially rescues the reduction in cell viability. Overexpression of Sarrah in mice shows better recovery of cardiac contractile function after AMI compared to control mice. In summary, we identified the anti-apoptotic evolutionary conserved lncRNA Sarrah , which is downregulated by aging, as a regulator of cardiomyocyte survival.
Abstract licence: CC BY-NC-ND
References66
- 8.
- 14.
- 40.
- 46.
- 48.
- 55.
- 57.
- 60.
- 66.
Ensembl 2018 · 2017
57 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.